FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy

Pfizer Animal Health buys Microtek

Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!


Pfizer Animal Health has acquired British Columbia, Canada-based Microtek International, an innovator in aquaculture vaccines, R&D and healthcare diagnostic services. Terms of the deal haven't been disclosed.

"The time is right for Pfizer Animal Health to enter the global market for aquaculture healthcare therapeutics," says Juan Ramon Alaix, president, Pfizer Animal Health. "The integration of Microtek R&D into Pfizer Animal Health also will allow us to build a more diverse and innovative portfolio in biopharmaceuticals."

Pfizer Animal Health has been busy over the past few years, acquiring R&D and a product line-up from Vetnex Animal Health Limited in India; establishing Pfizer Animal Genetics in 2008; and enhancing its poultry health business by acquiring R&D and innovative in-ovo vaccination technology from Embrex in 2007. the company says in a statement.

Jan Burian, Microtek's VP of R&D and production, said in an interview that Microtek's employees are positive about the deal, according to the Vancouver Sun. He added that Microtek's 10 employees will likely keep their jobs for now, and that Pfizer intends to build new facilities on Vancouver Island. "It's positive, because our research and development program was always good but we didn't have the capital to get through. Now, with the financial power of Pfizer, we're hoping it's a step in a new direction."

- see the Pfizer release
- get more from the Vancouver Sun

Related Article:
Sanofi, Merck prep for animal health sales
Boehringer corrals Wy-Pfi animal assets
Merck CEO talks up new Merial J.V.

Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FierceVaccines Email Newsletter:

More stories about Mergers and Acquisitions   Pfizer Animal Health   Microtek International